Trials / Completed
CompletedNCT00639379
Comparison of Two Toric Contact Lenses on Current Toric Wearers
A Multi-Center, Subject Masked, Randomized, Two Week Crossover Design, Investigation of the Acuvue Cypress Toric Silicone Hydrogel Lens Compared to the Bausch & Lomb SofLens66® Toric Hydrophilic Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate and compare the clinical performance of two toric contact lenses amongst 110 subjects, 2-week, single masked (subject), daily wear, randomized, bilateral, crossover study; 4 weeks duration. Hypotheses include equal or better performance of the test lens over the control lenses for comfort, vision, and toric fit characteristics as well as corneal integrity
Detailed description
Up to 7 sites in the US will participate. Each investigator will have both test and control lens types. There will be a maximum of 6 scheduled visits: Visit 1: Habitual lens evaluation / Baseline / Trial fitting Visit 2: Dispensing (to be combined with Visit 1 where possible), Visit 3: Questionnaire only (no exam) 7 days (±2) after dispensing, Visit 4: 2 week follow-up 14 days (±3) after dispensing, and dispense second lens type, Visit 5: Questionnaire only (no exam) 7 days (±2) after 2nd lens dispense, Visit 6: 2 week follow-up 14 days (±3) after 2nd lens dispense
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | senofilcon A toric | silicone hydrogel toric lens, 2 wk replacement, daily wear |
| DEVICE | alphafilcon A toric | hydrogel toric lens, 2 wk replacement, daily wear |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-03-20
- Last updated
- 2015-05-21
- Results posted
- 2010-07-19
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00639379. Inclusion in this directory is not an endorsement.